vascular ectasia vessel wall protrusion
Conditions
Interventions
None listed
Sponsors
Radboud Universitair Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: adults (age: 18 to 80) with an unruptured intracranial aneurysm treated with Surpass.
Exclusion criteria
Exclusion criteria: subarachnoid hemorrhage, earlier coiled aneurysm, allergy (hypersensitivity to iobitridol, history of major immediate or delayed skin reaction to Iobitridol injection) or contraindication to contrast agent (manifest thyrotoxicosis, recent treatment with intravenous interleukin 2), use of nephrotoxic medicines (aminoglycosides, organoplatinum compounds, high doses of methotrexate, pentamidine, foscarnet, aciclovir, ganciclovir, valaciclovir, adefovir, cidofovir, tenofovir, vancomycin, amphotericin B, immunosuppressants such as ciclosporine or tacrolimus, ifosfamide), contraindication to CT scan, renal insufficiency, pregnancy, and age
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main parameter is the difference in the degree of aneurysm occlusion. This will be measured by: - Calculation of the aneurysm volume with residual contrast filling. - The Raymond classification. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary parameters: The patency of the parent vessel will be measured on a 4-point scale. Complications will be registered. | — |
Countries
Netherlands
Outcome results
None listed